Ronaldo, who has been using Bioniq's tailored supplements since joining in 2022, has been a regular user for nearly three years. His investment not only highlights his dedication to enhancing his performance and overall health, both on and off the pitch, but also underscores the growing relevance of vitamins, minerals, and supplements among elite athletes and consumers focused on health optimisation. He is also set to collaborate on future brand and product innovations.

Now available in more than 70 countries, Bioniq has seen its user base grow more than fivefold in 2024. The company's approach, powered by top-tier scientists and a proprietary algorithm, merges advanced blood biomarker analysis with user-reported health data. This enables Bioniq to craft fully personalised supplements tailored to individual health needs, transforming the way personal health is managed. With a precision-driven platform, Bioniq formulates unique daily supplements for each user, designed to meet essential nutritional requirements and progressively optimise nutrient levels.

"Backing Bioniq goes beyond just an investment opportunity for me – it's about aligning with a shared vision for health, performance, and longevity,” said Cristiano Ronaldo. “I have been using their products myself for almost three years. With their personalised health approach, I believe Bioniq has the potential to transform how we care for our bodies and help people reach and maintain their peak performance for longer.”

Ronaldo’s investment marks a pivotal moment for Bioniq as it accelerates global expansion with particular focus on the US, Europe, and the Middle East – driving innovation in the booming wellness market, with the US now contributing over 60% of total global sales. His strategic involvement in product development, shaped by his unique performance needs and firsthand experience throughout various stages of his career, brings invaluable insight to Bioniq. As an athlete who has excelled across age categories, Ronaldo’s contributions will be instrumental to Bioniq’s approach to personalised health solutions. His support will further propel the company’s mission to deliver precision nutritional supplementation to millions, empowering them to achieve optimal health outcomes.

Bioniq’s ability to provide quantifiable before-and-after snapshots of users’ nutrient needs and optimisation progress has been an invaluable asset in its partnerships with many leading health and sports institutions such as Lanserhof and UFC. Bioniq has also become the product of choice for many other of the world's top athletes from Soccer World Cup Champions, NBA All-Stars to Iron Man winners.

“Cristiano Ronaldo is the perfect partner and shareholder. As the ultimate embodiment of performance and longevity, Cristiano fully aligns with the values and mission of Bioniq,” said Vadim Fedotov, Co-Founder and CEO of Bioniq. “We are thrilled that the world’s leading athlete and advocate of a healthy lifestyle has made Bioniq part of his journey since 2022. His personal experience with our products reinforces his belief in what we’re building. Cristiano’s decision to invest, highlights his confidence in our team's vision and his commitment to helping us build the leading company in personalised health.”

Bioniq has built the largest proprietary biochemical database of its kind, leveraging blood test data from customers across five continents. This follows Ronaldo's investment and a successful Series B, which raised $15 million led by Principal Investors HV Capital and Unbound, two leading European VCs. The AI-powered patent-pending Bioniq algorithm assesses an individual’s height, weight, age, lifestyle, and health goals to precisely identify micronutrient imbalances and deliver nutritional insights, daily nutrient support, and 1:1 nutrition consultations and educational resources.

“The personalised health and nutrition market is expansive, and Bioniq is leading the way with its innovative approach to personalisation,” said David Kuczek, General Partner at HV Capital. “Cristiano using Bioniq to enhance his performance shows that our product delivers real results. If it works for an elite athlete of his caliber, it’s clear that it can benefit ambitious consumers, helping them reach their own health and performance goals.”

“Bioniq is transforming personalised health through advanced AI technology. Cristiano’s partnership emphasises the global potential of this approach and supports our vision to lead innovation in the wellness industry,” Shravin Mittal Founder of Unbound.

All of Bioniq’s supplements are Swiss-made, pharmaceutical-grade and utilise precise micro-dosing to address bio-individual needs and deficiencies. Each formula is created specifically for an individual user and features a unique mix of up to 120 antioxidants, vitamins, minerals, phytonutrients, amino acids, and prebiotic fibre. Rather than traditional pills and capsules, the product is delivered in patented prebiotic guar granules, which are designed to mimic the way the body digests food, minimising nutrient competition and maximising bioavailability.

For more startup news, check out the other articles on the website, and subscribe to the magazine for free. Listen to The Cereal Entrepreneur podcast for more interviews with entrepreneurs and big-hitters in the startup ecosystem.